2022
DOI: 10.3389/fmolb.2022.1036287
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma

Abstract: Background: Increasing evidence supports that the APOBEC family is associated with development of a variety of cancers. However, the function of APOBEC1/3A/3G/3H in pancreatic adenocarcinoma (PAAD) is still unclear.Methods: Comprehensive bioinformatic analysis using R (version 3.6.3), TISIDB, Metascape etc. were performed to study the clinicopathological characteristics, prognostic value, immune features and functional mechanisms of the APOBEC1/3A/3G/3H in PAAD.Results: APOBEC1/3A/3G/3H showed significantly el… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…Allelic differences in the mismatch repair gene Msh3 m odify the stability of repeats in mice and in tumours (Maksimov et al., 2023). Evolving populations of cancer cells can co‐opt established mechanisms that generate variation, such as enzymatic cytosine deamination by AID/APOBEC (Conticello, 2008; Duan et al., 2022). For example, not only is APOBEC1 expressed in oesophageal adenocarcinomas, but its mutational signature is observed there (Saraconi et al., 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Allelic differences in the mismatch repair gene Msh3 m odify the stability of repeats in mice and in tumours (Maksimov et al., 2023). Evolving populations of cancer cells can co‐opt established mechanisms that generate variation, such as enzymatic cytosine deamination by AID/APOBEC (Conticello, 2008; Duan et al., 2022). For example, not only is APOBEC1 expressed in oesophageal adenocarcinomas, but its mutational signature is observed there (Saraconi et al., 2014).…”
Section: Introductionmentioning
confidence: 99%